These findings collectively suggest that FOXA1 acts as a negative regulator of cell proliferation, migration, and invasion in NPC cell lines, highlighting its potential as a tumor suppressor and a promising target for NPC therapeutic intervention. This evidence concerns the gene FOXA1 and nasopharyngeal carcinoma.